Філіппіни - англійська - FDA (Food And Drug Administration)

metz pharmaceuticals inc. - zinc - chewable tablet - 10 mg (equivalent to 70 mg zinc gluconate)

Філіппіни - англійська - FDA (Food And Drug Administration)

gogenerx pharma. inc. - zinc - capsule - 50mg (equivalent to 220mg zinc sulfate heptahydrate)

Філіппіни - англійська - FDA (Food And Drug Administration)

metz pharmaceuticals, inc. - zinc - film-coated tablet - 10 mg (equivalent to 27.45 mg zinc sulfate)

Філіппіни - англійська - FDA (Food And Drug Administration)

metz pharmaceuticals inc. - zinc - film-coated tablet - 10 mg (equivalent to 70 mg zinc gluconate)

Філіппіни - англійська - FDA (Food And Drug Administration)

metz pharmaceuticals, inc,; importer: n/a; distributor: n/a - zinc - film-coated tablet - 10mg (equivalent to 47.35mg zinc picolinate)

Філіппіни - англійська - FDA (Food And Drug Administration)

phil asia pharma, inc. - ciprofloxacin (as hydrochloride) - film-coated tablet - 500 mg

США - англійська - NLM (National Library of Medicine)

fosun pharma usa inc - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for

Філіппіни - англійська - FDA (Food And Drug Administration)

ece pharmaceuticals, inc. - multivitamins , lysine, zinc , taurine - syrup - 2,000iu, 5mg, 2mg, 2mg, 1mcg, 100mg, 400iu, 30mg, 100mg, 10mg (equi. to 44mg zinc sulfate), 50mg

США - англійська - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc

США - англійська - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate tablets usp are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures.                                                                                                                                   topiramate tablets are indicated as adjunctive therapy for adults and pediatric patients 2 to 16 years of age with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome. topiramate tablets are indicated for patients 12 years of age and older for the prophylaxis of migraine headache. none pregnancy category d   [see   warnings and precautions 5.7 ] topiramate  can cause fetal harm when administered to a pregnant woman. data from pregnancy registries indicate that infants exposed to topiramate in utero have an increased risk for cleft lip and/or cleft palate (oral clefts)